Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Novartis AG NVSEF OTC

Other OTC • Healthcare • Drug Manufacturers - General • CH • USD

SharesGrow Score
73/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Novartis AG (NVSEF) — Analyst outlook / Analyst consensus target is. Based on 20 analyst ratings, the consensus is bullish — 1 Strong Buy, 4 Buy, 14 Hold, 1 Sell.

NVSEF Analyst Ratings

Hold
20
Ratings
5 Buy
14 Hold
1 Sell
Based on 20 analysts giving stock ratings to Novartis AG in the past 3 months
Rating breakdown
Strong Buy
1 5%
Buy
4 20%
Hold
14 70%
Sell
1 5%
25%
Buy
5 analysts
70%
Hold
14 analysts
5%
Sell
1 analysts

People Also View

RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 RHHVF
RHHVF
Roche Holding AG
$403.29
+8.69%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 AZNCF
AZNCF
AstraZeneca PLC
$189.90
-1.35%
 GSK
GSK
GSK plc
$59.18
+0.41%
 SNY
SNY
Sanofi
$47.64
+1.45%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message